This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ethypharm, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Patrick Sanial
Introduction
Patrick Sanial is an accomplished inventor based in Morainvilliers, France. He is known for his significant contributions to the pharmaceutical industry, particularly in the development of innovative drug delivery systems. His work focuses on creating effective and user-friendly medication forms.
Latest Patents
One of Patrick Sanial's notable patents is for low-dose tablets and their preparation method. This invention involves a microgranule tablet that comprises a low dose of active principle, utilizing a directly compressible diluent. The unique aspect of this invention is that the diluent consists exclusively of neutral microgranules, with the active principle set on these microgranules without any coating that alters its release or masks its taste. This innovation enhances the effectiveness and palatability of medications.
Career Highlights
Patrick Sanial has made significant strides in his career, particularly through his work at Ethypharm, Inc. His expertise in pharmaceutical formulations has led to advancements in how medications are delivered to patients. His dedication to improving drug formulations has positioned him as a key figure in the industry.
Collaborations
Throughout his career, Patrick has collaborated with notable colleagues, including Guy Couaraze and Bernard Leclerc. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Patrick Sanial's contributions to the field of pharmaceuticals, particularly through his innovative patent for low-dose tablets, highlight his commitment to enhancing medication delivery. His work continues to impact the industry positively, making him a noteworthy inventor in the realm of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
